Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Corticotropin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Corticotrophins |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Product containing tetracosactide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
cosyntrophine 250 microgrammes/1mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
cosyntrophine 1 mg/1mL pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Cosyntropin preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Product containing corticotropin zinc hydroxide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Product containing corticotropin releasing factor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Cosyntropin 50mcg/mannitol 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Corticotrophins adverse reaction (disorder) |
Causative agent (attribute) |
False |
Corticotropin |
Inferred relationship |
Some |
|
Corticotrophins allergy |
Causative agent (attribute) |
False |
Corticotropin |
Inferred relationship |
Some |
|
Cosyntropin 25mcg/mannitol 10mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|
Corticotropin 80units/mL in gelatin injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Corticotropin |
Inferred relationship |
Some |
|